Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Flaig

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Hematotherapy & Stem Cell Research|May 2, 2002
Bone marrow transplantation for nonmalignant diseasesNabil Saba, Thomas Flaig
Ultrasonics|December 19, 2006
The effect of ultrasonic irradiation on doxorubicin-induced cytotoxicity in three human bladder cancer cell linesCaroline Arthur, Thomas Flaig, Lih-Jen Su, et al.
Oncology (Williston Park, N.Y.)|June 1, 2007
Prostate cancer in a man with multiple previous cancersThomas Flaig, E David Crawford, Brian Kavanagh, et al.
Frontiers in Oncology|July 18, 2022
Patterns of Treatment and Outcomes in Older Men With Penile Cancer: A SEER Dataset AnalysisMaria T Bourlon, Haydee Verduzco-Aguirre, Elizabeth Molina, et al.
Urologic Oncology|April 28, 2024
Cost of upper tract imaging obtained during hematuria evaluation: Analysis of a national claims databaseAlex Hannemann, Rodrigo Rodrigues Pessoa, Thomas Flaig, et al.
Clinical Genitourinary Cancer|April 24, 2020
Phase 2 Trial of GTx-758, an Estrogen Receptor Alpha Agonist, in Men With Castration-Resistant Prostate CancerEvan Y Yu, Michael L Hancock, William Aronson, et al.
Radiation Oncology (London, England)|April 12, 2011
Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local controlMichelle A Stinauer, Brian D Kavanagh, Tracey E Schefter, et al.
JCO Oncology Practice|December 21, 2023
Use of Peripheral Intravenous Access in Patients Undergoing Chemotherapy for Testicular CancerBrett Wiesen, Michael Atwell, Colton Leavitt, et al.
Oncology (Williston Park, N.Y.)|January 28, 2022
Management of Residual Disease After First-line Chemotherapy in a Patient With a Nonseminomatous Germ Cell TumorRegina Barragán-Carrillo, Samantha Mateos-Corella, Carlos Ortiz-Hidalgo, et al.
Urologic Oncology|April 6, 2021
National trends in clinical and pathologic staging for upper tract urothelial carcinoma: Implications for neoadjuvant chemotherapyRodrigo Rodrigues Pessoa, Jeffrey C Morrison, Badrinath Konety, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Hematotherapy & Stem Cell Research|May 2, 2002
Bone marrow transplantation for nonmalignant diseasesNabil Saba, Thomas Flaig
Ultrasonics|December 19, 2006
The effect of ultrasonic irradiation on doxorubicin-induced cytotoxicity in three human bladder cancer cell linesCaroline Arthur, Thomas Flaig, Lih-Jen Su, et al.
Oncology (Williston Park, N.Y.)|June 1, 2007
Prostate cancer in a man with multiple previous cancersThomas Flaig, E David Crawford, Brian Kavanagh, et al.
Frontiers in Oncology|July 18, 2022
Patterns of Treatment and Outcomes in Older Men With Penile Cancer: A SEER Dataset AnalysisMaria T Bourlon, Haydee Verduzco-Aguirre, Elizabeth Molina, et al.
Urologic Oncology|April 28, 2024
Cost of upper tract imaging obtained during hematuria evaluation: Analysis of a national claims databaseAlex Hannemann, Rodrigo Rodrigues Pessoa, Thomas Flaig, et al.
Clinical Genitourinary Cancer|April 24, 2020
Phase 2 Trial of GTx-758, an Estrogen Receptor Alpha Agonist, in Men With Castration-Resistant Prostate CancerEvan Y Yu, Michael L Hancock, William Aronson, et al.
Radiation Oncology (London, England)|April 12, 2011
Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local controlMichelle A Stinauer, Brian D Kavanagh, Tracey E Schefter, et al.
JCO Oncology Practice|December 21, 2023
Use of Peripheral Intravenous Access in Patients Undergoing Chemotherapy for Testicular CancerBrett Wiesen, Michael Atwell, Colton Leavitt, et al.
Oncology (Williston Park, N.Y.)|January 28, 2022
Management of Residual Disease After First-line Chemotherapy in a Patient With a Nonseminomatous Germ Cell TumorRegina Barragán-Carrillo, Samantha Mateos-Corella, Carlos Ortiz-Hidalgo, et al.
Urologic Oncology|April 6, 2021
National trends in clinical and pathologic staging for upper tract urothelial carcinoma: Implications for neoadjuvant chemotherapyRodrigo Rodrigues Pessoa, Jeffrey C Morrison, Badrinath Konety, et al.
Pageof 2